Posted by Michael Wonder on 01 Apr 2017
Agenda for 5 April 2017 TC meeting
31 March 2017 - HAS has posted the agenda for the next scheduled TC meeting.
The Transparency Commission will consider the reimbursement of:
- Sebelipase alfa (Kanuma)
- Etelcalcetide hydrochloride (Parsabiv)
- Palbociclib (Ibrance)
